David Guzo

Array ( [id] => 6892040 [patent_doc_number] => 20010018202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Lentiviral vectors derived from SIVagm, methods for their preparation and their use for gene transfer into mammalian cells' [patent_app_type] => new [patent_app_number] => 09/734384 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2148 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018202.pdf [firstpage_image] =>[orig_patent_app_number] => 09734384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1162643 [patent_doc_number] => 06759243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-06 [patent_title] => 'High affinity TCR proteins and methods' [patent_app_type] => B2 [patent_app_number] => 09/731242 [patent_app_country] => US [patent_app_date] => 2000-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14628 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/759/06759243.pdf [firstpage_image] =>[orig_patent_app_number] => 09731242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1227903 [patent_doc_number] => 06696251 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-02-24 [patent_title] => 'Yeast cell surface display of proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/724108 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 36 [patent_no_of_words] => 23707 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/696/06696251.pdf [firstpage_image] =>[orig_patent_app_number] => 09724108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580855 [patent_doc_number] => 06423538 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Yeast cell surface display of proteins and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/724297 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 36 [patent_no_of_words] => 23690 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423538.pdf [firstpage_image] =>[orig_patent_app_number] => 09724297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1092484 [patent_doc_number] => 06824976 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Method for selective inactivation of viral replication' [patent_app_type] => B1 [patent_app_number] => 09/724380 [patent_app_country] => US [patent_app_date] => 2000-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 51267 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/824/06824976.pdf [firstpage_image] =>[orig_patent_app_number] => 09724380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098354 [patent_doc_number] => 06818209 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Retroviral delivery system' [patent_app_type] => B1 [patent_app_number] => 09/701014 [patent_app_country] => US [patent_app_date] => 2000-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14159 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818209.pdf [firstpage_image] =>[orig_patent_app_number] => 09701014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 790497 [patent_doc_number] => 06984517 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-01-10 [patent_title] => 'AAV5 vector and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/717789 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 17195 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/984/06984517.pdf [firstpage_image] =>[orig_patent_app_number] => 09717789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396002 [patent_doc_number] => 06545138 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Process for producing composite preparation containing nucleic acid' [patent_app_type] => B1 [patent_app_number] => 09/701072 [patent_app_country] => US [patent_app_date] => 2000-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5549 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/545/06545138.pdf [firstpage_image] =>[orig_patent_app_number] => 09701072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7645794 [patent_doc_number] => 06472175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-29 [patent_title] => 'Sialylation of N-linked glycoproteins in the baculovirus expression vector system' [patent_app_type] => B1 [patent_app_number] => 09/714085 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 10464 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/472/06472175.pdf [firstpage_image] =>[orig_patent_app_number] => 09714085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1024076 [patent_doc_number] => 06884431 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-04-26 [patent_title] => 'Method for treating proliferative diseases with p27 and fusions thereof' [patent_app_type] => utility [patent_app_number] => 09/708276 [patent_app_country] => US [patent_app_date] => 2000-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8259 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/884/06884431.pdf [firstpage_image] =>[orig_patent_app_number] => 09708276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531789 [patent_doc_number] => 06410244 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Method for preparing plasmids, and uses related thereto' [patent_app_type] => B1 [patent_app_number] => 09/704230 [patent_app_country] => US [patent_app_date] => 2000-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2470 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410244.pdf [firstpage_image] =>[orig_patent_app_number] => 09704230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1148917 [patent_doc_number] => 06770481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'Gene isolation method' [patent_app_type] => B1 [patent_app_number] => 09/690885 [patent_app_country] => US [patent_app_date] => 2000-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 0 [patent_no_of_words] => 18936 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770481.pdf [firstpage_image] =>[orig_patent_app_number] => 09690885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1317656 [patent_doc_number] => 06608191 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-08-19 [patent_title] => 'Compositions and methods for treatment of hepatitis C virus-associated diseases' [patent_app_type] => B1 [patent_app_number] => 09/690936 [patent_app_country] => US [patent_app_date] => 2000-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13590 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/608/06608191.pdf [firstpage_image] =>[orig_patent_app_number] => 09690936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1147289 [patent_doc_number] => 06770283 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-08-03 [patent_title] => 'DNA expression systems based on alphaviruses' [patent_app_type] => B1 [patent_app_number] => 09/688842 [patent_app_country] => US [patent_app_date] => 2000-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 38 [patent_no_of_words] => 28223 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770283.pdf [firstpage_image] =>[orig_patent_app_number] => 09688842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1065468 [patent_doc_number] => 06846658 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-01-25 [patent_title] => 'Method for cloning and producing the Msel restriction endonuclease' [patent_app_type] => utility [patent_app_number] => 09/689343 [patent_app_country] => US [patent_app_date] => 2000-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 13947 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/846/06846658.pdf [firstpage_image] =>[orig_patent_app_number] => 09689343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342621 [patent_doc_number] => 06582691 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-24 [patent_title] => 'Expression vector for the production of dead proteins' [patent_app_type] => B1 [patent_app_number] => 09/601537 [patent_app_country] => US [patent_app_date] => 2000-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8772 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/582/06582691.pdf [firstpage_image] =>[orig_patent_app_number] => 09601537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550087 [patent_doc_number] => 06399385 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Methods for rapid PEG-modification of viral vectors, compositions for enhanced gene transduction, compositions with enhanced physical stability, and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/670277 [patent_app_country] => US [patent_app_date] => 2000-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 15179 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399385.pdf [firstpage_image] =>[orig_patent_app_number] => 09670277 [rel_patent_id] =>[rel_patent_doc_number] =>)